François Vergez - Concepedia

Author

François Vergez

Also Known As

F Vergez, F. Vergez, Francois Vergez, François Vergez, François Vergez, Gérard Schmit, Vergez, Fabien, Vergez, Francois, Vergez, François

474

Publications

Citations

H-Index

Concepts

All Affiliations

Inserm Université Toulouse III - Paul Sabatier Centre de Recherche en Cancérologie de Toulouse Centre Hospitalier Universitaire de Toulouse Centre National de la Recherche Scientifique

About

François Vergez is an author at Inserm specializing in medicine, cancer research, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	609
2	Health Sciences	6	6	198
3	Biostatistics	3	3	57
4	Engineering	1	1	12
5	Public Health	1	1	11

François Vergez

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism Thomas Farge, Estelle Saland, Fabienne de Toni, Cancer Discovery	2017	877
Assessment of tumor-infiltrating TCRV<b>γ</b>9V<b>δ</b>2<b>γδ</b>lymphocyte abundance by deconvolution of human cancers microarrays Marie Tosolini, Frédéric Pont, Mary Poupot, OncoImmunology	2017	179
High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells Laury Poulain, Pierre Sujobert, Florence Zylbersztejn, Leukemia Hematological MalignancyMolecular PharmacologyG6pd InhibitionGlycolysis AddictionMedicine	2017	140
Proteasome inhibitors induce FLT3-ITD degradation through autophagy in AML cells Clément Larrue, Estelle Saland, Héléna Boutzen, Blood	2015	122
Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia Sarah Bertoli, Emilie Bérard, Françoise Huguet, Blood	2013	118
Ferritin heavy/light chain (FTH1/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia Sarah Bertoli, Étienne Paubelle, Emilie Bérard, European Journal Of Haematology	2018	115
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia Claudie Bosc, Estelle Saland, Aurélie Bousard, Nature Cancer Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaMalignant Blood Disorder	2021	106
Dendrogenin A drives LXR to trigger lethal autophagy in cancers Grégory Segala, Marion David, Philippe de Médina, Nature Communications	2017	101
The ROS/SUMO Axis Contributes to the Response of Acute Myeloid Leukemia Cells to Chemotherapeutic Drugs Guillaume Bossis, Jean-Emmanuel Sarry, Chamseddine Kifagi, Cell Reports	2014	96
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial Xavier Leleu, Cyrille Hulin, Jérôme Lambert, Nature Medicine	2024	87

Page 1